Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessa Pardo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|February 26, 2013
SNAP-tag technology: a general introductionKatharina Kolberg, Christiane Puettmann, Alessa Pardo, et al.
Protein Expression and Purification|February 12, 2008
Eukaryotic expression and secretion of EGFP-labeled annexin A5Michael Stöcker, Alessa Pardo, Christian Hetzel, et al.
Applied Microbiology and Biotechnology|October 3, 2015
Targeting c-kit receptor in neuroblastomas and colorectal cancers using stem cell factor (SCF)-based recombinant bacterial toxinsSwati Choudhary, Alessa Pardo, Reinhard Rosinke, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2012
In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour modelAlessa Pardo, Michael Stöcker, Florian Kampmeier, et al.
Journal of Cancer Research and Clinical Oncology|July 2, 2017
Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancerClaudia Kessler, Alessa Pardo, Mehmet K Tur, et al.
Cancer Letters|April 19, 2015
Targeted killing of rhabdomyosarcoma cells by a MAP-based human cytolytic fusion proteinHannes Brehm, Dmitrij Hristodorov, Alessa Pardo, et al.
Theranostics|August 27, 2014
Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomographyFelix Gremse, Benjamin Theek, Sijumon Kunjachan, et al.
Cancer Letters|July 13, 2014
A CSPG4-specific immunotoxin kills rhabdomyosarcoma cells and binds to primary tumor tissuesHannes Brehm, Judith Niesen, Radoslav Mladenov, et al.
Journal of Cancer Research and Clinical Oncology|December 1, 2014
In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cellsJudith Niesen, Hannes Brehm, Christoph Stein, et al.
Current Pharmaceutical Design|February 26, 2013
SNAP-tag based agents for preclinical in vitro imaging in malignant diseasesManal Amoury, Tobias Blume, Hannes Brehm, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|February 26, 2013
SNAP-tag technology: a general introductionKatharina Kolberg, Christiane Puettmann, Alessa Pardo, et al.
Protein Expression and Purification|February 12, 2008
Eukaryotic expression and secretion of EGFP-labeled annexin A5Michael Stöcker, Alessa Pardo, Christian Hetzel, et al.
Applied Microbiology and Biotechnology|October 3, 2015
Targeting c-kit receptor in neuroblastomas and colorectal cancers using stem cell factor (SCF)-based recombinant bacterial toxinsSwati Choudhary, Alessa Pardo, Reinhard Rosinke, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2012
In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour modelAlessa Pardo, Michael Stöcker, Florian Kampmeier, et al.
Journal of Cancer Research and Clinical Oncology|July 2, 2017
Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancerClaudia Kessler, Alessa Pardo, Mehmet K Tur, et al.
Cancer Letters|April 19, 2015
Targeted killing of rhabdomyosarcoma cells by a MAP-based human cytolytic fusion proteinHannes Brehm, Dmitrij Hristodorov, Alessa Pardo, et al.
Theranostics|August 27, 2014
Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomographyFelix Gremse, Benjamin Theek, Sijumon Kunjachan, et al.
Cancer Letters|July 13, 2014
A CSPG4-specific immunotoxin kills rhabdomyosarcoma cells and binds to primary tumor tissuesHannes Brehm, Judith Niesen, Radoslav Mladenov, et al.
Journal of Cancer Research and Clinical Oncology|December 1, 2014
In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cellsJudith Niesen, Hannes Brehm, Christoph Stein, et al.
Current Pharmaceutical Design|February 26, 2013
SNAP-tag based agents for preclinical in vitro imaging in malignant diseasesManal Amoury, Tobias Blume, Hannes Brehm, et al.
Pageof 2